HealthEquity, Inc. (NASDAQ:HQY – Get Rating) has been assigned an average rating of “Moderate Buy” from the fifteen brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and seven have assigne. HealthEquity, Inc. (NASDAQ:HQY – Get Rating) was the target of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 3,120,000 shares, a decline of 12.1% from the October 31st total of 3,550,000 shares. Based on an average daily trading volume, of 848,200 shares, the short-interest ratio is presently 3.7 days. Approximately 3.8% of the shares of the company are sold short.According to Bloomberg, the sixteen rating agencies that cover HealthEquity, Inc. (NASDAQ: HQY) have given the stock an average rating of “Moderate Buy,”.

Read up-to-the-minute investing news with MarketBeat’s instant stock market news alerts.During September, there was a meteoric increase in the number of short positions held in HealthEquity, Inc. (NASDAQ: HQY). There were 4,310,000 shares. In a research note distributed to investors on Wednesday, stock analysts at Robert W. Baird increased HealthEquity’s (NASDAQ: HQY) price objective from. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

PHR Stock Forecast, Price & News (Phreesia)

Researching Phreesia? Get The Latest PHR Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Researching The Ensign Group? Get The Latest ENSG Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.Shares of AltaGas Ltd. (TSE:ALA – Get Rating) have received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on. .